Potential of Selected Trace Elements in Patients with Diabetes Mellitus

Open access

Abstract

Based on the high prevalence, diabetes mellitus (DM) is considered as a worldwide problem. More than 8.3 % of the world population is suffering from this disease. One of the causing factors of this disease can be the absence or imbalance of trace, essential elements. It can cause collapses of antioxidant defence and glucose intolerance. It plays a role in the pathogenesis and progression to diabetes mellitus. This review focuses on chromium, copper, selenium, vanadium, and zinc. Many studies deal with these elements but there is variability in opinions. Insulin-mimetic activity and ability to control the concentrations of blood glucose were confirmed. However, these effects were of more importance in patients with prediabetes. In patients with prediabetes, due to the supplementation of selected trace elements, it is possible to normalize the blood glucose level and prevent the development of diabetes mellitus. The importance of supplementation was confirmed for chromium and zinc. The supplementation of vanadium has a positive effect on the normalization of glycaemia but it is necessary to control the level as it can have toxic effects during long-term treatment. Conversely, higher copper concentrations in the body adversely affect patients and chelation therapy is needed. Selenium must be kept in the standard concentration and regular control of the concentration in the body is necessary. For this reason it is necessary to continue with analysis and the creation of new methodologies that could unify the view on the issue.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • 1. International Diabetes Federation. Diabetes Atlas 7th ed. Belgium: Brussel; 2015.

  • 2. Viswabath B Choi ChS Lee K Kim S. Recent trends in the development of diagnostic tools for diabetes mellitus using patient saliva. Trends Analyt Chem 2017; 89: 60–7.

  • 3. Mokáň M Martinka E Galajda P. Diabetes mellitus a vybrané metabolické ochorenia. Slovakia: Martin; 2008.

  • 4. Kruse-Jarres JD Rükgauer M. Trace elements in diabetes mellitus. Peculiarities and clinical validity of determinations in blood cells. J Trace Elem Med Biol 2000; 14: 21–7.

  • 5. Panchal SK Wanyonyi S Bown L. Selenium Vanadium and Chromium as Micronutrients to Improve Metabolic Syndrome. Curr Hypertens Rep 2017; 19 (10): 11.

  • 6. Zhang H Yan C Yang Z Zhang W Niu Y Li X Qin L Su Q. Alterations of serum trace elements in patients with type 2 diabetes. J Trace Elem Med Biol 2017; 40 (1): 91-6.

  • 7. Cancarini J. Trace elements and diabetes: Assessment of levels in tears and serum. Exp Eye Res 2017; 154: 47-52.

  • 8. Vincent JB. The bioinorganic chemistry of chromium (III). Polyhedron 2001; 20 (68): 1–26.

  • 9. Marcinkowska M Baralkiewicz D. Multielemental speciation analysis by advanced hyphenated technique – HPLC/ICP-MS: A review. Talanta 2016; 161: 177-204.

  • 10. Bednar AJ Kirgan AA Jones WT. Comparison of standard and reaction cell inductively coupled plasma mass spectrometry in the determination of chromium and selenium species by HPLC–ICP–MS. Anal Chim Acta 2009; 632: 27-34.

  • 11. Buchancová J et al. Pracovné lekárstvo. Slovakia: Martin; 2003.

  • 12. Sreekanth R Pattabhi V Rajan SS. Molecular basis of chromium insulin interactions. Biochem Biophys Res Commun 2008; 369 (2): 725.

  • 13. Dobrota D et al. Lekárska biochémia. Slovakia: Martin; 2016.

  • 14. Weksler-Zangen S Mizrahi T Raz I Mirsky N. Glucccose tolerance factor extracted from yeast: oral insulin-mimetic and insulin-potentioting agent: in vivo and in vitro studies. Br J Nutr 2012; 108: 875-82.

  • 15. Sharma S Agrawal RP Choudhary M Jain S Goyal S Agarwal V. Beneficial effect of chromium supplementation on glucose HbA1C and lipid variables in individuals with newly onset type-2 diabetes. J Trace Elem Med Biol 2011; 25: 149-53.

  • 16. Peng M Yang X. Controlling diabetes by chromium complexes: The role of the ligands. J Inorg Biochem 2015; 146: 97-103.

  • 17. Eshak ES Hiroyasu I Koutatsu M Muraki I Tamakoshi A. Associations between dietary intakes of iron copper and zinc with risk of type 2 diabetes mellitus: A large population-based prospective cohort study. Clin Nutr 2018; 37 (2): 667-74.

  • 18. Lowe J Taveira-da-Silva R Hilário-Souza E. Dissecting Copper Homeostasis in Diabetes Mellitus. IUBMB Life 2017; 69 (4): 255-62.

  • 19. Qiu Q Zhang F Zhu W Wu J Liang M. Copper in Diabetes Mellitus: a Meta-Analysis and Systematic Review of Plasma and Serum Studies. Biol Trace Elem Res 2017; 177: 53-63.

  • 20. Skalnaya MG Skalny AV Tinkov AA. Serum copper zinc and iron levels and markers of carbohydrate metabolism in postmenopausal women with prediabetes and type 2 diabetes mellitus. J Tra ce Elem Med Biol 2017; 43: 46-51.

  • 21. Jamilian M Samimi M Ebrahimi FA Aghadavod E Mohammadbeigi R Rahimi M Asemi Z. Effects of Selenium Supplementation on Gene Expression Levels of Inflammatory Cytokines and Vascular Endothelial Growth Factor in Patients with Gestational Diabetes. Biol Trace Elem Res 2018; 181 (2): 199-206.

  • 22. Domingo JL Gómez M. Vanadium compounds for the treatment of human diabetes mellitus: A scientific curiosity? A review of thirty years of research. Food Chem Toxicol 2016; 95: 137–41.

  • 23. Ahmadi-Eslamloo H Dehghani GA Moosavi SMS. Long-term treatment of diabetic rats with vanadyl sulfate or insulin attenuate acute focal cerebral ischemia/reperfusion injury via their antiglycemic effect. Metab Brain Dis 2018; 33: 225-35.

  • 24. Mináriková D Minárik P. Liečebné a preventívne použitie zinku. Praktické lekárnictvo 2015; 5 (2): 47–50.

  • 25. Plum LM Rink L Hasse H. The Essential Toxin: Impact of Zinc on Human Health. Int J Environ Res Public Health 2010; 7 (4): 1342–65.

  • 26. Myers SA Nield A. Zinc Zinc Transporters and Type 2 Diabetes Endocrine Diseases. Hong Kong; 2014.

  • 27. Ranasinghe P Wathurapatha W Galappatthy P Katulanda P Jayawardena R Constantine GR. Zinc supplementation in prediabetes: A randomized double-blind placebo-controlled clinical trial. J Diabetes 2018; 10 (5): 386-97.

Search
Journal information
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 159 159 17
PDF Downloads 138 138 17